• Dougherty, Paul J., and Bradford K. Matthews. "Comparison of M-16A2 and M-4 Wounding Potential. ." Military Medicine172.8 (2007): 4. Web. 23 Aug. 2012. <http://ehis.ebscohost.com.proxy045.nclive.org/ehost/pdfviewer/pdfviewer?sid=2518c014-66bc-4aa6-b7eb-bcef928d5f87%40sessionmgr113&vid=9&hid=3>.
    1. The first combat use of the M-4 in Afghanistan in 2001 and 2002 raised concerns about the stopping power of the weapon compared to the M-16A2.
    2. “The wounding characteristics of the M-4 and the M-16A2 rifle were compared by using the 'would profile method.'”
    3. “Using the would profile method, shots were made into blocks of ordnance gelatin prepared to reproduce the wounding characteristics of soft tissue.”
    4. Would ballistics is the science that evaluates the pathophysiology and outcomes of wounds created by missiles.
    5. The would profile technique is used to demonstrate the amount of tissue disruption that may occur as a projectile passes through the tissue.
    6. The M16A2 had 3150 muzzle velocity compared to the M4's 2890.
    7. The M4 had a smaller muzzle velocity then the M16A2 because they M4 has a shorter barrel.
    8. The smaller muzzle velocity caused projectiles to fragment less upon entering a target (gelatin used to represent human tissue).
    9. The M16A2 produced a consistently higher muzzle velocity and a larger temporary cavity.
    10. The M4 carbine was adopted by the U.S. Military in 1994.
    11. The M16A2 demonstrated greater tissue disruption using the wound profile method, compared to the M4.
    12. The reason the M4 has less tissue disruption compared to the M16A2 is because of it's shorter barrel length.
    13. Compared to the M16A2, the M4 demonstrated a higher penetration depth.
    14. When the M-16A1 rifle was first fielded during the Vietnam War. anecdotal reports of erratic performance in wounding were noted in nonmedical articles.
    15. One of the reasons there was less tissue damage with the M16A2 is due to the bullet not breaking up upon entering the target.